Clinical Trial Update: Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the Endometrium [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a weight-loss drug as a fertility-sparing treatment for endometrial hyperplasia with atypical features and endometrial cancer; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Endometrial Hyperplasia with Atypical Features

Drugs mentioned

• Weight-loss drug

Snippet

Sponsor: University Health Network, Toronto | Conditions: Endometrial Cancer, Atypical Hyperplasia | Phase 2 | Status: NOT_YET_RECRUITING